Thursday, 5 November 2026European Markets

AKZO NOBEL And AIR LIQUIDE Have A High Dividend Yield And Return On Equity In The Specialty Chemicals Industry.

Loading stream...

(vianews) - akzo nobel (akza.as) is among this list of stock assets with the highest dividend rate and return on equity on the specialty chemicals industry.

financial asset price forward dividend yield return on equity
akzo nobel (akza.as) €56.42 3.47% 12.21%
air liquide (ai.pa) €164.20 1.67% 13.73%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. akzo nobel (akza.as)

3.47% forward dividend yield and 12.21% return on equity

akzo nobel n.v. engages in the production and sale of paints and coatings worldwide. the company operates through two segments: decorative paints and performance coatings. it offers decorative paints, including paints, lacquers, and varnishes; and a range of mixing machines and color concepts for the building and renovation industry, as well as specialty coatings. the company also provides performance coatings that protect and enhance ships, cars, aircraft, yachts, architectural components, consumer goods, and oil and gas facilities. it offers its products under akzonobel, alabastine, alba, andercol, apla, armstead trade, astral, astral batiment, awlgrip, brikol, dulux, bruguer, cetabever, cetol, chemcraft, colourland paints, consolan, coral, cromadex, cuprinol, dynacoat, flexa, glitsa, grip-gard, herbol, hammerite, international, interlux, innenweis, interpon, inca, luxol, levis, lesonal, molto, modern classikk, maxilite, mauvilac, mason ct, marshall, mactra, nordsjo, oxirite, protecto, procolor, polyfilla, polycell, pinotex, pintuco, resicoat, relest, sparlack, sadolin, sikkens, sea hawk, savana, salcomix, trimetal, titanlux, taubmans, u-tech, vpowdertech, vivechrom, xylazel, xyladecor, wanda, and zweihorn brands. the company serves to energy, packaging, infrastructure, and shipbuilding and maintenance industries, as well as general industries, such as agricultural and construction equipment, construction-related steel, metal fabrication, pipes, appliances, and transportation. the company was formerly known as akzo nv and changed its name to akzo nobel n.v. in 1994. akzo nobel n.v. was founded in 1646 and is headquartered in amsterdam, the netherlands.

earnings per share

as for profitability, akzo nobel has a trailing twelve months eps of €3.45.

pe ratio

akzo nobel has a trailing twelve months price to earnings ratio of 16.35. meaning, the purchaser of the share is investing €16.35 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.21%.

more news about akzo nobel.

2. air liquide (ai.pa)

1.67% forward dividend yield and 13.73% return on equity

l'air liquide s.a. provides gases, technologies, and services for the industrial and health sectors in europe, the americas, the asia pacific, the middle east, and africa. it operates in gas & services, engineering & construction, and global markets & technologies segments. the gas & services segment comprises large industries business, which offers gas and energy solutions including oxygen, nitrogen, argon, hydrogen, and carbon monoxide, as well as operates cogeneration plants to supply steam and electricity to metals, chemicals, refining, and energy industries; and industrial merchant business line provides industrial gases, equipment, hardgoods, and associated services to materials and energy, automotive and manufacturing, food and pharmaceuticals, technology and research, and craftsmen and retail sectors. this segment also includes healthcare business, which provides medical gases, home healthcare services, medical equipment, and specialty ingredient to patients, healthcare professionals, and hospitals; and electronic business supply carrier gases, electronic specialty and advanced materials, equipment and installation, and service to semiconductor, flat panel, and photovoltaic markets. the engineering & construction segment designs, develops, and builds industrial gas production plants to third parties; and design and manufacture plants in traditional, renewable and alternative energy sectors. the global markets & technologies segment delivers technological solutions, such as molecules, equipment, and services to energy transition and deep technology. this segment also invests in and operates biomethane production units; designs hydrogen refueling stations; and supplies gases for the offshore oil and gas platforms, offshore wind turbines, and cryogenic transportation by sea. l'air liquide s.a. was incorporated in 1902 and is headquartered in paris, france.

earnings per share

as for profitability, air liquide has a trailing twelve months eps of €5.33.

pe ratio

air liquide has a trailing twelve months price to earnings ratio of 30.81. meaning, the purchaser of the share is investing €30.81 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.73%.

moving average

air liquide's worth is below its 50-day moving average of €169.37 and above its 200-day moving average of €162.42.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on may 15, 2023, the estimated forward annual dividend rate is 2.95 and the estimated forward annual dividend yield is 1.67%.

volatility

air liquide's last week, last month's, and last quarter's current intraday variation average was a positive 0.07%, a negative 0.03%, and a positive 0.89%.

air liquide's highest amplitude of average volatility was 0.92% (last week), 0.93% (last month), and 0.89% (last quarter).

more news about air liquide.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com